This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Pernix Therapeutics Holdings Inc (PTX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents n.a. n.a. n.a. n.a.
Receivables n.a. n.a. n.a. n.a.
Inventories n.a. n.a. n.a. n.a.
Other Current Assets n.a. n.a. n.a. n.a.
Total Current Assets n.a. n.a. n.a. n.a.
Property, Plant & Equipment, Gross n.a. n.a. n.a. n.a.
Accumulated Depreciation & Depletion n.a. n.a. n.a. n.a.
Property, Plant & Equipment, Net n.a. n.a. n.a. n.a.
Intangibles 122.52M 141.22M 8.88M 10.96M
Other Non-Current Assets 88.87M 110.23M 73.69M 35.07M
Total Non-Current Assets 211.39M 251.45M 82.56M 46.03M
Liabilities & Shareholder Equity
Total Assets 211.39M 251.45M 82.56M 46.03M
Accounts Payable n.a. n.a. n.a. n.a.
Short Term Debt 17.00M 2.29M 6.00M 0.00
Other Current Liabilities n.a. n.a. n.a. n.a.
Total Current Liabilities n.a. n.a. n.a. n.a.
Long Term Debt 1.31M 41.35M 0.00 5.00M
Deferred Income Taxes n.a. n.a. n.a. n.a.
Other Non-Current Liabilities 82.35M 129.27M 26.94M 22.13M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 83.66M 170.62M 26.94M 27.13M
Total Liabilities 100.66M 172.91M 32.94M 27.13M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 110.72M 78.54M 49.62M 18.90M
Common Par 371.89K 296.03K 257.49K 226.28K
Additional Paid In Capital 119.55M 58.61M 30.19M 8.93M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -5.20M 20.43M 21.84M 13.50M
Treasury Stock -4.00M -3.77M -3.75M -3.75M
Other Equity Adjustments 0.00 2.98M 1.09M 0.00
Total Capitalization n.a. n.a. n.a. n.a.
Total Equity 110.72M 78.54M 49.62M 18.90M
Total Liabilities & Stock Equity 211.39M 251.45M 82.56M 46.03M
Total Common Shares Outstanding 37.19M 34.03M 25.75M 22.63M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 2.13M 2.07M 2.07M 2.07M
Basic Weighted Shares Outstanding 36.44M 28.15M 23.99M 23.42M
Diluted Weighted Shares Outstanding 36.44M 28.15M 24.46M 23.42M
Number of Employees 191 251 85 77
Number of Part-Time Employees 0 0 0 0
PTX News

PTX Pernix Therapeutics Holdings Inc

Analysts Ratings for PTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 1 1 1
Moderate Buy 0 0 0 0
Hold 0 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PTX ANALYST REPORT

Brokerage Partners

PTX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs